SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (1756)12/4/1999 7:59:00 PM
From: Eric Fader  Read Replies (2) of 5582
 
<he's a deceptive short seller>

He's more than deceptive. I believe "criminal" better describes his groundless allegations, and if any of the companies he libels gave a flying $%&k what he said he'd be looking at multiple summonses and complaints. I'll be very surprised if one whose behavior is so outrageous can escape legal trouble indefinitely.

And for the record, since we may now be in front of a new audience that reads the "hot" threads, I and members of my immediate family have used Zicam now a total of 11 times since January and have found that it dramatically shortened the duration of colds and/or dramatically reduced cold symptoms 7 times, completely eliminated 2 colds before they even kicked in, worked less dramatically once, and seemed not to help much or at all on one occasion. I'm ignoring the nicotine gum angle until there is a definitive announcement, but I too have been saying for a long time that come February or March, when Zicam is a household name, GUMM will have reached $30 per share. -Eric
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext